News
OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to ...
DataM Intelligence | competitive Intelligence MPS I market evolution accelerates as gene therapies and BBB-penetrant ERTs emerge, challengi ...
Lentiviral vectors (LVVs) have proven to be extremely versatile genetic delivery vehicles, gaining space as a gene transfer technology tool used both for cell and gene therapies. They are utilised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback